The bull case for SCHD: closing half its valuation gap at 18.6x look-through earnings supports $38.88 fair value, about 8% ...

Analysts favor, Roche and Merck; Lilly lifted 2026 guidance by over $5B, while Merck could recover after Keytruda generics ...

U.S. flights see more than 1,600 cancellations and nearly 3,600 delays Sunday; Duffy expects recovery Monday and seeks $50 ...

The State Street Energy Select Sector SPDR Premium Income ETF (XLEI) and Adams Natural Resources Fund (PEO) both earn Buy ...

Analyst rates Standard Motor Products a Buy: shares remain attractively valued after a 15% rally, supported by steady growth ...

The bull case for GPIQ: its lower yield leaves more room to capture a recovery than QQQI, whose roughly 15% yield carries ...

SpaceX discusses buying 1,200 acres near its Texas launch site, with 600 acres under permanent conservation easement; Boca ...

Impax Global Opportunities Fund portfolio delivered a positive return over the quarter but underperformed the MSCI ACWI by ...

Analysts rate Nvidia a Buy with a 12-month base case of about $227, citing its CEO-independent moat and 12x forward P/E, the ...

The bull case for Nvidia: after a 32% correction, shares could gain about 46% to the $238 base-case target, at around 10x ...

Nvidia urges Taiwan officials to reconsider an employee's treatment amid allegations that 74 servers went to China and ...

Analyst sees India benefiting from AI stock rotation, with $7.2 billion in net foreign buying; easing Iran tensions could ...